Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis
Recruiting · NCT06003283 · Registry updated 2025-05-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 4 | 2025-05-31 | NCT06003283 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fonds voor Wetenschappelijk Reumaonderzoek (FWRO) | 1 |
| Universitaire Ziekenhuizen KU Leuven | 262 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cliniques Universitaires Saint-Luc Bruxelles | Brussels | Belgium | 1 |
| OLV Aalst | Aalst | Belgium | 2 |
| Reumacentrum Genk | Genk | Belgium | 1 |
| ReumaClinic Genk | Genk | Belgium | 2 |
| RZ Heilig Hart | Leuven | Belgium | 1 |
| University Hospitals Leuven (UZ Leuven) | Leuven | Belgium | 1 |
| ZNA Jan Palfijn | Merksem | Belgium | 1 |